Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DEAD-box helicase 19A (DDX19A) is an ATP-dependent RNA helicase and member of the DEAD-box family of proteins, characterized by the conserved motif *Asp-Glu-Ala-Asp* (DEAD)[3]. DDX19A is responsible for binding and remodeling structured RNAs and RNA-protein complexes, performing ATP-driven unwinding of RNA helices. It is typically involved in the export of mature mRNA from the nucleus to the cytoplasm and participates broadly in RNA metabolism, including regulation of RNA folding, ribonucleoprotein (RNP) rearrangements, and maintaining proper RNA structure[1][2][3]. DEAD-box helicases, including DDX19A, function as general RNA chaperones, accelerating the remodeling and folding of structured RNAs by local unwinding and disruption of secondary and tertiary structures in an ATP-dependent manner[1][2]. Dysregulation of similar RNA helicases is linked to diseases such as cancer and infection, but DDX19A-specific roles are still being clarified[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DEAD-box helicase 19A (DDX19A).